Patent ID: 11944674
Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  Y | IPC A

Claim 3:
4. The fusion polypeptide or particle as claimed in claim 1, wherein the amino acid sequence of (i) is:
(a) a sequence having at least 80% sequence identity to SEQ ID NO: 16 and having the ability to induce protective immunity against P. vivax CSP; or
(b) a fragment of SEQ ID NO: 16 which is at least 50% of the length of SEQ ID NO: 16 and having the ability to induce protective immunity against P. vivax CSP;
and/or
wherein the amino acid sequence of (ii) is:
(a) a sequence having at least 80% sequence identity to SEQ ID NO: 18 and having the ability to induce protective immunity against P. vivax CSP; or
(b) a fragment of SEQ ID NO: 18 which is at least 50% of the length of SEQ ID NO: 18 and having the ability to induce protective immunity against P. vivax CSP.